- $626.55m
- $770.78m
- $1.05bn
- 91
- 90
- 99
- 100
2019 September 30th | 2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 847 | 823 | 730 | 886 | 1,049 |
Cost of Revenue | |||||
Gross Profit | 494 | 449 | 449 | 528 | 610 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 820 | 871 | 698 | 811 | 951 |
Operating Profit | 27.3 | -48.4 | 31.2 | 74.9 | 97.5 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 4.17 | -70.1 | 16.1 | 67.7 | 51.6 |
Provision for Income Taxes | |||||
Net Income After Taxes | 1.77 | -68.5 | 8.61 | 50.2 | 38.5 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 2.54 | -68.5 | 8.61 | 50.2 | 38.5 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 2.54 | -68.5 | 8.61 | 57.6 | 42.8 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.236 | -0.346 | 0.165 | 0.715 | 0.474 |